Infection of human dendritic cells with herpes simplex virus type 1 dramatically diminishes the mRNA levels of the prostaglandin E2 receptors EP2 and EP4

Immunobiology

Volumn 212, Issue 9-10, 2008, Pages 827-838

  Theodoridis, Alexandros A ^a   Prechtel, Alexander T ^a   Turza, Nadine M ^a   Zenke, Martin ^b   Steinkasserer, Alexander ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

CCR7; Dendritic cells; Herpes simplex virus type 1; Immune evasion; Migration; Prostaglandin E2

Indexed keywords

MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; VIRION; VIRUS GENE; VIRUS IMMUNITY; VIRUS MUTANT;

EID: 37049028564     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.09.002     Document Type: Article

References (66)

1. Ahn K., Meyer T.H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P.A., Fruh K., and Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15 (1996) 3247-3255
2. Allan R.S., Waithman J., Bedoui S., Jones C.M., Villadangos J.A., Zhan Y., Lew A.M., Shortman K., Heath W.R., and Carbone F.R. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25 (2006) 153-162
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.S., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
5. Belz G.T., Heath W.R., and Carbone F.R. The role of dendritic cell subsets in selection between tolerance and immunity. Immunol. Cell Biol. 80 (2002) 463-468
6. Blaney Jr. J.E., Nobusawa E., Brehm M.A., Bonneau R.H., Mylin L.M., Fu T.M., Kawaoka Y., and Tevethia S.S. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. J. Virol. 72 (1998) 9567-9574
7. Breyer R.M., Bagdassarian C.K., Myers S.A., and Breyer M.D. Prostanoid receptors: subtypes and signalling. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 661-690
8. Carbone F.R., Belz G.T., and Heath W.R. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trends Immunol. 25 (2004) 655-658
9. Caux C., Massacrier C., Vianbervliet B., Dubois B., Van Kooten C., Durand I., and Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180 (1994) 1263-1272
10. Cavanagh L.L., and Von Adrian U.H. Travellers in many guises: the origins and destinations of dendritic cells. Immunol. Cell Biol. 80 (2002) 448-462
11. Cella M., Engering A., Pinet V., Pieters J., and Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388 (1997) 782-787
12. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., and Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189 (1999) 821-829
13. Coffin R.S., Maclean A.R., Latchman D.S., and Brown S.M. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther. 3 (1996) 886-891
14. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 (1999) 2098-2102
15. Daheshia M., Feldman L.T., and Rouse B.T. Herpes simplex virus latency and the immune response. Curr. Opin. Microbiol. 1 (1998) 430-435
16. Deshpande S.P., Kumaraguru U., and Rouse B.T. Why do we lack an effective vaccine against herpes simplex virus infections?. Microb. Infect. 2 (2000) 973-978
17. Everly Jr. D.N., Feng P., Mian I.S., and Read G.S. mRNA degradation by the virion host shutoff (vhs) protein of herpes simplex virus: genetic and biochemical evidence that vhs is a nuclease. J. Virol. 76 (2002) 8560-8571
18. Förster R., Schubel A., Breitfeld D., Kremmer E., Renner-Muller I., Wolf E., and Lipp M. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 (1999) 23-33
19. Funk C.D. Prostaglandins and leukotriens: advances in eicosanoid biology. Science 294 (2001) 1871-1875
20. Gualde N., and Harizi H. Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunol. Cell Biol. 82 (2004) 353-360
21. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., and Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189 (1999) 451-460
22. Hagglund R., and Roizman B. Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J. Virol. 78 (2004) 2169-2178
23. Hart D.N. Dendritic cells: unique leukocyte populations wich control the primary immune response. Blood 90 (1997) 3245-3287
24. Jarrossay D., Napolitani G., Colonna M., Sallusto F., and Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 11 (2001) 3388-3393
25. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., and Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27 (1997) 3135-3142
26. Jugovic P., Hill A.M., Tomazin R., Ploegh H., and Johnson D.C. Inhibition of major histocompatibility complex I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2. J. Virol. 72 (1998) 5076-5084
27. Kalinski P., Vieira P.L., Schuitemaker J.H., de Jong E.C., and Kapsenberg M.L. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97 (2001) 3466-3469
28. Kamphuis W., Schneemann A., van Beek L.M., Smit A.B., Hoyng P.F., and Koya E. Prostanoid receptor gene expression profile in human trabecular meshwork: a quantitative real-time PCR approach. Invest. Ophthalmol. Vis. Sci. 42 (2001) 3209-3215
29. Kellermann S.A., Hudak S., Oldham E.R., Liu Y.J., and McEvoy L.M. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 162 (1999) 3859-3864
30. Kobelt D., Lechmann M., and Steinkasserer A. The interaction between dendritic cells and herpes simplex virus-1. Curr. Top. Microbiol. Immunol. 276 (2003) 145-161
31. Kruse M., Rosorius O., Kratzer F., Stelz G., Kuhnt C., Schuler G., Hauber J., and Steinkasserer A. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74 (2000) 7127-7136
32. Legler D.F., Krause P., Scandella E., Singer E., and Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts ist effects via EP2 and EP4 receptors. J. Immunol. 176 (2006) 966-973
33. Lilley C.E., Groutsi F., Han Z., Palmer J.A., Anderson P.N., Latchman D.S., and Coffin R.S. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J Virol 75 (2001) 4343-4356
34. Loré K., Betts M.R., Brenchley J.M., Kuruppu J., Khojasteh S., Perfetto S., Roederer M., Seder R.A., and Koup R.A. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 171 (2003) 4320-4328
35. Luft T., Jefford M., Luetjens P., Toy T., Hochrein H., Masterman K.A., Maliszewski C., Shortman K., Cebon J., and Maraskovsky E. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100 (2002) 1362-1372
36. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams M.C., Gale N.W., Iwasaki A., and Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101 (2004) 5598-5603
37. Luther S.A., Tang H.L., Hyman P.L., Farr A.G., and Cyster J.G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl. Acad. Sci. USA 97 (2000) 12694-12699
38. Mazzoni A., and Segal D.M. Controlling the Toll road to dendritic cell polarization. J. Leukoc. Biol. 75 (2004) 721-730
39. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001) 255-258
40. Mikloska Z., Bosnjak L., and Cunningham A.L. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75 (2001) 5958-5964
41. Montoya M., Schiavoni G., Mattei F., Gresser I., Belardelli F., Borrow P., and Tough D.F. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99 (2002) 3263-3271
42. Mueller S.N., Jones C.M., Smith C.M., Heath W.R., and Carbone F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195 (2002) 651-656
43. Novak N., and Peng W.M. Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells. Clin. Exp. Immunol. 142 (2005) 405-410
44. Ohl L., Mohaupt M., Czeloth N., Hintzen G., Kiafard Z., Zwirner J., Blankenstein T., Henning G., and Förster R. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21 (2004) 279-288
45. Oroskar A.A., and Read G.S. Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 63 (1989) 1897-1906
46. Parkinson J., and Everett R.D. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J. Virol. 74 (2000) 10006-10017
47. Parlato S., Santini S.M., Lapenta C., Di Pucchio T., Logozzi M., Spada M., Giammarioli A.M., Malorni W., Fais S., and Belardelli F. Expression of CCR-7, MIP-3beta, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 98 (2001) 3022-3029
48. Pollara G., Katz D.R., and Chain B.M. The host response to herpes simplex virus infection. Curr. Opin. Infect. Dis. 17 (2004) 199-203
49. Prechtel A.T., Turza N.M., Kobelt D.J., Eisemann J.I., Coffin R.S., McGrath Y., Hacker C., Ju X., Zenke M., and Steinkasserer A. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 86 (2005) 1645-1657
50. Prechtel A.T., Turza N.M., Theodoridis A.A., Kummer M., and Steinkasserer A. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation. J. Immunol. Methods 311 (2006) 139-152
51. Randolph G.J. Migratory dendritic cells: sometimes simply ferries?. Immunity 25 (2006) 15-18
52. Rocca B., and FitzGerald G.A. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2 (2002) 603-630
53. Roizman B. Whither herpesviruses?. Adv. Exp. Med. Biol. 278 (1990) 285-291
54. Sallusto F., and Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179 (1994) 1109-1118
55. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182 (1995) 389-400
56. Samady L., Costigliola E., MacCormac L., McGrath Y., Cleverley S., Lilley C.E., Smith J., Latchman D.S., Chain B., and Coffin R.S. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy. J. Virol. 77 (2003) 3768-3776
57. Scandella E., Men Y., Gillessen S., Förster R., and Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100 (2002) 1354-1361
58. Scandella E., Men Y., Legler D.F., Gillessen S., Prikler L., Ludewig B., and Groettrup M. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103 (2004) 1595-1601
59. Smiley J.R. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?. J. Virol. 78 (2004) 1063-1068
60. Smith J.S., and Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186 Suppl. 1 (2002) S3-S28
61. Smith C.M., Belz G.T., Wilson N.S., Villadangos J.A., Shortman K., Carbone F.R., and Heath W.R. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170 (2003) 4437-4440
62. Smith C.M., Wilson N.S., Waithman J., Villadangos J.A., Carbone F.R., Heath W.R., and Belz G.T. Cognate CD4(+) T cell licensing of dendritic cells in CD8(+) T cell immunity. Nat. Immunol. 5 (2004) 1143-1148
63. Sodeik B., Ebersold M.W., and Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136 (1997) 1007-1021
64. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
65. Whitley R.J., and Roizman B. Herpes simplex virus infections. Lancet 357 (2001) 1513-1518
66. York I.A., Roop C., Andrews D.W., Riddell S.R., Graham F.L., and Johnson D.C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77 (1994) 525-535